Tag "Bermekimab"

Janssen completes acquisition of investigational Bermekimab

Janssen completes acquisition of investigational Bermekimab

1 year ago 0

The Janssen Pharmaceutical Companies announced the acquisition of all rights to Bermekimab, along with certain employees, from XBiotech Inc., for $750 million. The Janssen Pharmaceutical

Loading, Please Wait!

This may take a second or two. Loading, Please Wait!
×
BOOK YOUR STAND

Please fill our short form.

Company Name (required)

Your Name (required)

Designation (required)

Number (required)

Your Email (required)

X